Riot Platforms, Inc. — Director's Dealing 2012

May 2, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AspenBio Pharma, Inc. (APPY)
CIK: 0001167419
Period of Report: 2012-04-30

Reporting Person: Lundy Steve (Director, President, CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-04-30	Stock Option (Right to Buy)	$0.66	A	75000	Acquired	2022-04-30	Common Stock (75000)	Direct

Footnotes

F1: The option to purchase 75,000 shares of common stock shall become exercisable as to 50% of the shares on October 30, 2012, as to 8.33% of the shares on November 30, 2012, as to 8.33% of the shares on December 31, 2012, as to 8.33% of the shares on January 31, 2013, as to 8.33% of the shares on February 28, 2013, as to 8.34% of the shares on March 31, 2013, and as to 8.34% of the shares on April 30, 2013.